p53 Nuclear Accumulation and Multiploidy Are Adverse Prognostic Factors in Surgically Resected Stage II Colorectal Cancers Independent of Fluorouracil-Based Adjuvant Therapy
Open Access
- 1 September 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (3) , 360-368
Abstract
To identify the prognostically highest risk patients, DNA content and p53 nuclear or cytoplasmic accumulation, evaluated by monoclonal antibody DO7 aKeywords
This publication has 28 references indexed in Scilit:
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerThe Lancet, 1997
- A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancerEuropean Journal of Cancer, 1997
- DNA Ploidy, Cell Kinetics, and Epidermal Growth Factor Receptor and HER2/neu Oncoprotein Expression in Primary Operable Breast CanceraAnnals of the New York Academy of Sciences, 1996
- Five-year prospective study of DNA tumor ploidy and colorectal cancer survivalCancer, 1995
- p53 and behaviour of colorectal cancerThe Lancet, 1994
- Cytoplasmic Accumulation of p53 Protein: an Independent Prognostic Indicator in Colorectal AdenocarcinomasJNCI: Journal of the National Cancer Institute, 1994
- An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasmsThe Journal of Pathology, 1994
- Consensus review of the clinical utility of dna flow cytometry in colorectal cancerCytometry, 1993
- Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinomaThe Lancet, 1992
- MULTIPLE GENETIC ALTERATIONS IN DISTAL AND PROXIMAL COLORECTAL CANCERThe Lancet, 1989